American Healthcare REIT, Inc. (AHR) Stock: Price, Forecast & Analyst Target
American Healthcare REIT, Inc. (AHR) — MoonshotScore 58/100 (Fair band), calculated Oct 5, 2026. Price $50.75 (0.00%), as of the Oct 5, 2026 trading session; market cap $10.5B. Expected results Nov 5, 2026.
Educational signal · not a buy or sell recommendation · How to read this
Market value / cash and short-term investments: 66.92× (market value Oct 5, 2026; cash Jun 30, 2026) · expected results Nov 5, 2026
American Healthcare REIT, Inc. · AHR · NYSE · Real Estate · REIT - Healthcare Facilities
Research dated 2026-09-13: American Healthcare REIT owns healthcare properties spanning medical offices, senior housing, skilled nursing facilities and integrated senior health campuses through an internal management platform. It is not merely a landlord collecting rent: resident fees and services dominate reported segment revenue, tying results directly to activity within the properties. Durable value requires that resident-fee growth keep translating into operating cash after property spending without allowing debt to constrain the platform.
Price as of Oct 5, 2026
Key Statistics
MoonshotScore v2 · American Healthcare REIT (AHR)
FairWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
A strong balance sheet, but weak growth and a full valuation; the market is already moving on it. Business Quality: Average; Financial Safety: Sound; Valuation: Rich; Growth Durability: Fading; Momentum: Surging.
- quarterly revenue $674M (Q2 FY2026, quarter ended Jun 2026)
- EPS beat 1 of 8
- Altman Z 3.20 · Piotroski F 5
Holding back: a rich price
Helping: balance-sheet strength, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 60 | Fair | |
| 60 | Fair | |
| 60 | Fair | |
| 60 | Fair | |
| 59 | Fair | |
| 59 | Fair |
The score was 58 in the stored Oct 4, 2026 snapshot and remains 58 in the current publication computed Oct 5, 2026 (0); the largest pillar moves were Growth Durability +6; the pillar moves offset under the sector-relative weighting, so the headline score is unchanged. This current publication is not yet represented in the immutable snapshot archive.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · Educational signal · not a buy or sell recommendation · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $50.75 | |
| Change on the day | 0.00% | |
| 52-week range | $40.00 – $58.70 | |
| Market capitalisation | $10.5B | |
| Price / earnings (trailing) | 74.56 | |
| Shares traded on the day | 1.13M | |
| Beta (volatility vs the S&P 500) | 0.75 | |
| Dividends per share (last 12 months) | $1.00 | |
| Dividend yield (last 12 months) | 1.97% |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · below the recorded estimate
- · Earnings results · below the recorded estimate
- · Earnings results · below the recorded estimate
- · Earnings results · above the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
Chronological order, not a duration scale. The provider's estimated date can change.
What to watch nextOther perspectives
Council score for American Healthcare REIT (AHR): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
4 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 24, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 24, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 24, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Oct 5, 2026, except a card that shows its own read date.
Watch the AHR film — every key number, told as a short cinematic story
~2 min · open the film
What is American Healthcare REIT (AHR), and what does it report?
Short answer · as of
American Healthcare REIT combines a diversified healthcare property portfolio with an internal team that manages the assets.
Research dated 2026-09-13.
American Healthcare REIT combines a diversified healthcare property portfolio with an internal team that manages the assets. Its footprint crosses several care settings and extends across the United States and the United Kingdom.
Reported segment revenue is labeled Resident Fees and Services. Revenue therefore measures much more than contractual rent: it reflects the economic activity generated by residents and services across the managed portfolio, while operating profit captures the effect of property and service costs.
What do the latest results show for American Healthcare REIT (AHR)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $674M.
Research dated 2026-09-13.
The most recent period extended the rise in revenue, while operating profit, net income, diluted earnings and operating cash flow improved from the preceding period. Revenue and diluted earnings also cleared consensus after a stretch in which earnings repeatedly fell short of expectations.
Resident demand and fee capture feed the dominant revenue stream, while the cost of running properties and delivering services governs how much reaches profit and cash flow. The latest statement nevertheless pairs positive operating profit with negative gross profit, an internally awkward combination that warrants reconciliation before using the gross margin as a clean operating signal.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
- Latest quarter · revenue
- $674.25M Jun 30, 2026
- Latest quarter · SG&A
- $37.50B Jun 30, 2026
- Latest quarter · FMP standardized operating result
- $45.58M Jun 30, 2026
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Jun 30, 2026 | $674.25M | Not available | $37.50B | $45.58M |
| Mar 31, 2026 | $650.77M | Not available | $30.70M | $40.84M |
| Dec 31, 2025 | $604.08M | Not available | $28.74M | $39.73M |
| Sep 30, 2025 | $572.94M | Not available | $26.70M | $42.53M |
USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $670.96M Aug 6, 2026
- Latest report · revenue estimate
- $645.30M Aug 6, 2026
- Latest report · revenue vs estimate
- Above estimate Aug 6, 2026
- Latest report · EPS vs estimate
- Above estimate Aug 6, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Aug 6, 2026 | $670.96M | $645.30M | $0.1600 | $0.1372 |
| May 7, 2026 | $650.77M | $667.57M | $0.1300 | $0.1609 |
| Feb 26, 2026 | $604.08M | $609.48M | $0.0600 | $0.1549 |
| Nov 6, 2025 | $572.94M | $615.39M | $0.3300 | $0.4200 |
Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $674M | $31M | $0.16 (diluted) |
| Q1 FY2026 | $651M | $24M | $0.13 (diluted) |
| Q4 FY2025 | $604M | $11M | $0.06 (diluted) |
| Q3 FY2025 | $573M | $56M | $0.33 (diluted) |
What are the financial strengths and risks for American Healthcare REIT (AHR)?
Short answer
Cash and short-term investments were $156.90M at the Jun 30, 2026 balance-sheet date. Operating cash flow was $118.62M for the quarter ended Jun 30, 2026, meaning operations generated cash. These figures do not establish a cash runway.
Research dated 2026-09-13.
Operating cash flow strengthened materially, property spending remained below operating cash flow in the latest period, and cash plus short-term investments reached the highest balance in the presented history. The business has also moved from annual losses to profit, giving the improvement support beyond a solitary reporting period.
Debt still far exceeds cash and investments, while current liquidity ratios remain thin. Because resident fees dominate reported segment revenue, weaker resident activity or rising property and service costs could pressure profit and cash generation even if the real estate remains occupied.
The per-share distribution has remained unchanged across the recent payment history. Its durability should be judged alongside operating cash generation, property spending and debt obligations rather than net income alone.
Data-derived red flags
- Inconsistent delivery — missed Wall Street EPS estimates in 7 of the last 8 reported quarters.
- Rich valuation — a P/E of 74.56 runs well above the Real Estate sector’s ~30.50x, leaving little room for a miss.
How much cash does the business generate or use?
Quarterly operating cash flow shows cash generated or used by operations.
- Latest quarter · operating cash flow
- $118.62M Jun 30, 2026
- Previous quarter · operating cash flow
- $88.06M Mar 31, 2026
| Period end | Operating cash flow | Capital expenditure (reported) |
|---|---|---|
| Jun 30, 2026 | $118.62M | −$47.69M |
| Mar 31, 2026 | $88.06M | −$38.32M |
| Dec 31, 2025 | $55.17M | −$69.26M |
| Sep 30, 2025 | $107.19M | $48.08M |
Operating cash-flow bars share one scale and show magnitude; negative values mean cash used.
USD. Negative operating cash flow means cash used. Capital expenditure keeps the provider’s reported sign; it is not added here to estimate free cash flow or runway.
What should you watch next at American Healthcare REIT (AHR)?
Short answer · as of
The next earnings report is expected on Nov 5, 2026.
Research dated 2026-09-13.
Resident-fee momentum, operating cash conversion and the unusual gross-profit presentation deserve attention in the forthcoming results. Near-term consensus calls for a further revenue step-up while diluted earnings remain level with the latest reported outcome, so execution can be checked against a clearly defined baseline.
Cash should also be read against debt and property spending: continued cash accumulation would strengthen financial flexibility, whereas weaker conversion could make leverage more restrictive. Longer-range estimates assume continued expansion, although analyst coverage becomes thinner further into the forecast horizon.
Recent filings include notices concerning departures or appointments of principal officers, and the leadership roster identifies an executive on leave. Clear responsibility across the senior team matters while the operating platform and portfolio continue to expand.
How does American Healthcare REIT compare with its peers?
Short answer
American Healthcare REIT's score ranks 3rd of 3 in the bounded comparison shown, against 2 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-13.
American Healthcare REIT differs from a pure lease-spread healthcare landlord because its reported revenue is concentrated in resident fees and services. That structure places resident activity and service economics closer to the income statement than a rent-led reading would suggest.
Its portfolio also spans medical offices, senior housing, skilled nursing facilities and integrated senior health campuses across domestic and international markets. Breadth by property type and geography sits alongside concentration in the reported revenue category, while the internal management platform makes property execution central to financial performance.
| Company | Price | Market value | Score |
|---|---|---|---|
| $27.39 Oct 2, 2026 | $8.41B | 70 5-pillar Oct 5, 2026 | |
| $65.88 Oct 2, 2026 | $7.91B | 69 5-pillar Oct 5, 2026 | |
| American Healthcare REIT (AHR) — this page | $50.75 | $10.5B | 58 |
| $178.32 Oct 5, 2026 | $66.0B | — Model unavailable | |
| $106.08 Oct 5, 2026 | $9.16B | — Model unavailable | |
| $59.76 Oct 5, 2026 | $7.92B | — Model unavailable | |
| $36.30 Date unavailable | $8.58B | — Model unavailable | |
| $19.49 Date unavailable | $13.4B | — Model unavailable | |
| $45.72 Date unavailable | $13.7B | — Model unavailable | |
| $19.16 Date unavailable | $4.83B | — Model unavailable | |
| $65.72 Date unavailable | $3.19B | — Model unavailable | |
| $84.01 Date unavailable | $40.8B | — Model unavailable | |
| $70.98 Date unavailable | $2.20B | — Model unavailable |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $61.00 – $70.00
- Consensus target
- $64.71
- Median target
- $65.00
Consensus record · Captured .
Measured against a quoted price of $50.75 (as of Oct 5, 2026).
Insider activity
Form 4 records via FMP · Of the newest 60 records, those within the last 180 days, newest dated Sep 25, 2026
- Transactions
- 22
- Identified insiders
- 12
- Purchases
- 0
- Sales
- 4
- Other transactions
- 18
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
- Reporting holders
- 580 Period end Jun 30, 2026
- Previous quarter · holders
- 524 Prior to period end Jun 30, 2026
| Holders in provider snapshot | Shares |
|---|---|
| Blackrock, INC. | 25,845,948 |
| Vanguard Portfolio Management LLC | 16,975,438 |
| Vanguard Capital Management LLC | 9,201,599 |
| State Street Corp | 9,046,025 |
| Principal Financial Group INC | 8,917,875 |
Quarterly filings lag the period end. Holder rows are names in the provider snapshot, not a verified ranking; individual filing dates are not supplied. Related managers may appear separately, so these positions are not summed. Holder snapshot as of Jun 30, 2026.
What has been published about American Healthcare REIT (AHR)?
What Investors Ask About American Healthcare REIT (AHR) — Real Estate
Research dated 2026-09-13; the answers below are from that research, and the full attribution is under Sources. The last 3 questions are answered from this page's own dated data, not from the research.
Why are Resident Fees and Services central to American Healthcare REIT?
They dominate reported segment revenue, making resident activity and service delivery primary links between the property portfolio and reported growth. This differs from reading AHR as a landlord driven mainly by contractual rent.
What does American Healthcare REIT’s negative gross-profit line mean?
It sits beside positive operating profit in the same statement, so it should not be treated as a clean deterioration signal without reconciliation. Revenue, net income and operating cash flow improved at the same time.
How exposed is AHR to debt despite its rising cash balance?
Debt remains far above cash and investments even after cash reached the highest balance in the presented history. Stronger operating cash flow helps, but leverage still limits how freely the company can fund property spending and distributions.
Why do integrated senior health campuses change how AHR should be read?
They place property ownership alongside resident services within an internally managed portfolio. Revenue can therefore respond to resident activity and fee capture, while operating results remain exposed to the costs of running the campuses.
What is the AHR stock price today?
The last price recorded on this page for American Healthcare REIT, Inc. (AHR) is $50.75, as of the Oct 5, 2026 trading session (source: Financial Modeling Prep (FMP) · quote). It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the AHR price target?
The analyst consensus price target for American Healthcare REIT, Inc. (AHR) is $64.71 (range $61.00 to $70.00, median $65.00), per FMP data captured Oct 5, 2026. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Does AHR pay a dividend?
Yes. American Healthcare REIT, Inc. (AHR) shows a trailing 12-month dividend yield of 1.97%, as of Oct 2, 2026, in the data on this page. Payout ratio and cash-flow coverage decide whether it can last, and past dividends do not guarantee future payments.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are shown with each answer. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (78 figures)
The 78 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
OFFICIAL — 1 fact from SEC filings and earnings calls
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
id.hq | SEC filing business address | 18191 VON Karman Avenue, Suite 300, Irvine, CA, 92612 | OFFICIAL | SEC EDGAR filer business address — The SEC filer business address. Our market-data provider separately lists "18191 Von Karman Avenue, Irvine, CA, 92612-7106, US". |
FMP — 67 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
earn.next | Next earnings date | Nov 5, 2026 | FMP | Financial Modeling Prep (FMP) earnings calendar — The date is our provider's estimate until the company confirms it. | |
px.last | Latest provided price | $50.75 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-05T17:14:40.433Z. | |
px.change | Change on the day | 0.00% | FMP | Financial Modeling Prep (FMP) · quote | |
px.mcap | Market capitalisation | $10.5B | FMP | Financial Modeling Prep (FMP) · quote — Date unknown Market cap record date: 2026-10-05. FMP quote timestamp: 2026-10-05T17:14:35.000Z. Captured from FMP at 2026-10-05T17:14:38.697Z. No share-count basis is inferred; this page preserves the reported amount instead of recalculating it from shares. | |
px.change_abs | Change on the day, in dollars | $0.00 | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q2 FY2026 | $674M | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
px.pe | Price / earnings (trailing) | 74.56 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 1.13M | FMP | Financial Modeling Prep (FMP) · quote | |
px.beta | Beta | 0.75 | FMP | Financial Modeling Prep (FMP) company profile | |
id.ceo | Chief executive | Jeffrey T. Hanson | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) — Titles and pay come from the company's proxy statement as our provider parsed it. | |
id.employees | Employees | 121 | FMP | Financial Modeling Prep (FMP) employee count, from the company's filing | |
fin.annual | Revenue and net result by fiscal year | 5 fiscal years, FY2021 through FY2025: FY2021 revenue $1.26B, net result −$47.79M; FY2022 revenue $1.62B, net result −$81.30M; FY2023 revenue $1.86B, net result −$71.47M; FY2024 revenue $2.07B, net result −$37.81M; FY2025 revenue $2.26B, net result $69.81M | FMP | Financial Modeling Prep (FMP), from the company's 10-K income statements | |
fin.rev_mix | Reported revenue segments | Resident Fees and Services $2.09B | FMP | Financial Modeling Prep (FMP) revenue segmentation, from the company's 10-K | |
fin.gross_margin | Gross margin (trailing twelve months) | 14.9% | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero. | |
fin.q_table.depth.2026-06-30.revenue_k | Revenue — period end 2026-06-30 | $674.25M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-06-30.sga_k | SG&A — period end 2026-06-30 | $37.50B | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-06-30.operating_result_k | FMP standardized operating result — period end 2026-06-30 | $45.58M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.revenue_k | Revenue — period end 2026-03-31 | $650.77M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.sga_k | SG&A — period end 2026-03-31 | $30.70M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2026-03-31.operating_result_k | FMP standardized operating result — period end 2026-03-31 | $40.84M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.revenue_k | Revenue — period end 2025-12-31 | $604.08M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.sga_k | SG&A — period end 2025-12-31 | $28.74M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-12-31.operating_result_k | FMP standardized operating result — period end 2025-12-31 | $39.73M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.revenue_k | Revenue — period end 2025-09-30 | $572.94M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.sga_k | SG&A — period end 2025-09-30 | $26.70M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
fin.q_table.depth.2025-09-30.operating_result_k | FMP standardized operating result — period end 2025-09-30 | $42.53M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements — Quarterly statement note |
earn.history.depth.2026-08-06.revenue_actual | Revenue · reported — report date 2026-08-06 | $670.96M | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-08-06.revenue_estimated | Revenue · estimate — report date 2026-08-06 | $645.30M | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-08-06.eps_actual | EPS · reported — report date 2026-08-06 | $0.1600 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-08-06.eps_estimated | EPS · estimate — report date 2026-08-06 | $0.1372 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-05-07.revenue_actual | Revenue · reported — report date 2026-05-07 | $650.77M | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-05-07.revenue_estimated | Revenue · estimate — report date 2026-05-07 | $667.57M | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-05-07.eps_actual | EPS · reported — report date 2026-05-07 | $0.1300 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-05-07.eps_estimated | EPS · estimate — report date 2026-05-07 | $0.1609 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-26.revenue_actual | Revenue · reported — report date 2026-02-26 | $604.08M | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-26.revenue_estimated | Revenue · estimate — report date 2026-02-26 | $609.48M | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-26.eps_actual | EPS · reported — report date 2026-02-26 | $0.0600 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2026-02-26.eps_estimated | EPS · estimate — report date 2026-02-26 | $0.1549 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-11-06.revenue_actual | Revenue · reported — report date 2025-11-06 | $572.94M | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-11-06.revenue_estimated | Revenue · estimate — report date 2025-11-06 | $615.39M | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-11-06.eps_actual | EPS · reported — report date 2025-11-06 | $0.3300 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
earn.history.depth.2025-11-06.eps_estimated | EPS · estimate — report date 2025-11-06 | $0.4200 | Report date · | FMP | Financial Modeling Prep (FMP) earnings — Earnings-history note |
fin.q_table | Quarterly income statement | 4 quarters through Q2 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
fin.cash_investments | Cash and short-term investments | $156.90M | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review. | |
fin.opcf_latest | Latest-quarter operating cash flow | $118.62M | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Period end: 2026-06-30. Negative operating cash flow means cash used. This figure is not a cash-runway estimate. | |
fin.long_term_investments | Long-term investments (classification unverified) | $92.46M | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | |
fin.total_debt | Total debt | $1.57B | FMP | Financial Modeling Prep (FMP), from the company's balance sheet — Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | |
fin.price_to_book | Price to book value | 2.61× | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm — A ratio our provider could not compute is absent rather than shown as zero. | |
fin.opcf.depth.2026-06-30.operating_cash_flow_m | Operating cash flow — period end 2026-06-30 | $118.62M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-03-31.operating_cash_flow_m | Operating cash flow — period end 2026-03-31 | $88.06M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-06-30.capex_m | Capital expenditure (reported) — period end 2026-06-30 | −$47.69M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2026-03-31.capex_m | Capital expenditure (reported) — period end 2026-03-31 | −$38.32M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-12-31.operating_cash_flow_m | Operating cash flow — period end 2025-12-31 | $55.17M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-12-31.capex_m | Capital expenditure (reported) — period end 2025-12-31 | −$69.26M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-09-30.operating_cash_flow_m | Operating cash flow — period end 2025-09-30 | $107.19M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
fin.opcf.depth.2025-09-30.capex_m | Capital expenditure (reported) — period end 2025-09-30 | $48.08M | Period end · | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements — Cash-flow note |
earn.pt_range | Analyst price target, low to high | $61.00 – $70.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 5, 2026 · Coverage not supplied | |
earn.pt_consensus | Consensus analyst price target | $64.71 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 5, 2026 · Coverage not supplied | |
earn.pt_median | Median analyst price target | $65.00 | FMP | Financial Modeling Prep (FMP) · price-target consensus — Captured Oct 5, 2026 · Coverage not supplied | |
own.insiders | Insider transactions via FMP | 22 transactions · 0 purchases, 4 sales, 18 other transactions · 12 identified insiders · of the newest 60 records, those within the last 180 days, newest dated Sep 25, 2026 | FMP | Financial Modeling Prep (FMP), carrying Form 4 transaction records — Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent. | |
own.institutions.depth.holders | Reporting holders | 580 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Period end Jun 30, 2026 | |
own.institutions.depth.holders_previous_quarter | Previous quarter · holders | 524 | FMP | Financial Modeling Prep (FMP) institutional ownership summary, from 13F filings — 13F filings are quarterly and lag the quarter end by up to 45 days. Prior to period end Jun 30, 2026 | |
own.top_holders.depth.holder_0.shares | Blackrock, INC. — shares in provider snapshot | 25,845,948 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_1.shares | Vanguard Portfolio Management LLC — shares in provider snapshot | 16,975,438 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_2.shares | Vanguard Capital Management LLC — shares in provider snapshot | 9,201,599 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_3.shares | State Street Corp — shares in provider snapshot | 9,046,025 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. | |
own.top_holders.depth.holder_4.shares | Principal Financial Group INC — shares in provider snapshot | 8,917,875 | FMP | Financial Modeling Prep (FMP) institutional holders, from 13F filings — Provider snapshot as of 2026-06-30; individual filing date not supplied. |
UNRECORDED — 3 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
earn.history | Reported versus estimated, recent quarters | EPS beat 1 of 8 | UNRECORDED | Stored earnings-history observation — Captured 2026-10-04 | |
fin.scores | Distress and quality screens | Altman Z 3.20 · Piotroski F 5 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-04 · Expired observation | |
px.range52 | 52-week range | $40.00 – $58.70 | UNRECORDED | Stored company-profile observation — Captured 2026-10-04 |
COMPUTED — 5 facts from our arithmetic, formula restated
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
fin.mcap_to_cash | Market value per dollar of cash and short-term investments | 66.92× | — | COMPUTED | Computed on this page from the figures above — The market capitalisation printed on this page divided by cash and short-term investments of $156.90M at Jun 30, 2026. Long-term investments are excluded and remain unclassified. Restrictions on cash and short-term investments require separate review. Market cap record date: 2026-10-05. Balance-sheet reference date: 2026-06-30. The inputs do not establish a single common source date for this ratio. |
div.ttm_per_share | Dividends per share, last 12 months (split-adjusted) | $1.00 | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history — Sum of 4 split-adjusted declared dividends with an ex-date in the 365 days to 2026-10-05, per current share. Ex-dates are not payment dates; special dividends are included. Not a declared annual rate. | |
div.ttm_yield | Dividend yield, last 12 months | 1.97% | COMPUTED | Financial Modeling Prep (FMP) split-adjusted dividend history and quote — Split-adjusted dividends with ex-dates in the trailing 365-day window divided by the packet price, on the same current-share basis. Price date follows the quote, latest price bar or packet-build day when unstamped. Not a forecast or declared annual rate. | |
earn.history.depth.2026-08-06.revenue_actual.comparison | Latest report · revenue vs estimate | Above estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported revenue ($670.96M) with the recorded estimate ($645.30M) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
earn.history.depth.2026-08-06.eps_actual.comparison | Latest report · EPS vs estimate | Above estimate | Report date · | COMPUTED | Computed from Financial Modeling Prep (FMP) earnings — Earnings-history note — Method: compare reported EPS ($0.1600) with the recorded estimate ($0.1372) at displayed precision. Equal displayed values are in line. This compares reported results with recorded estimates, not investment returns. |
OURS — 2 facts from Stock Expert AI's own score and rank
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
ours.moonshot | MoonshotScore v2 | 58 of 100 · Fair · pillars 45 / 79 / 26 / 35 / 80 | OURS | Stock Expert AI MoonshotScore v2 engine | |
ours.moonshot_change | MoonshotScore movement | 58 (stored snapshot Oct 4, 2026) → 58 (current publication computed Oct 5, 2026) (0) | OURS | Stock Expert AI current score publication and immutable score snapshots — The current score publication is not yet represented in the immutable snapshot archive. |
Fact-family notes
- Quarterly statement note. Source series as of 2026-06-30. USD. The operating result is the FMP-standardized value supplied by FMP; it may differ from a filing’s GAAP loss from operations when the provider classifies separately presented items differently. It is not net income or cash flow. Applies to Fact IDs:
fin.q_table.depth.2026-06-30.revenue_k,fin.q_table.depth.2026-06-30.sga_k,fin.q_table.depth.2026-06-30.operating_result_k,fin.q_table.depth.2026-03-31.revenue_k,fin.q_table.depth.2026-03-31.sga_k,fin.q_table.depth.2026-03-31.operating_result_k,fin.q_table.depth.2025-12-31.revenue_k,fin.q_table.depth.2025-12-31.sga_k,fin.q_table.depth.2025-12-31.operating_result_k,fin.q_table.depth.2025-09-30.revenue_k,fin.q_table.depth.2025-09-30.sga_k,fin.q_table.depth.2025-09-30.operating_result_k. - Earnings-history note. Source series as of 2026-08-06. Dates are report dates, not fiscal period ends. Revenue is in USD; EPS is USD per share, rounded to four decimals. The earnings feed does not establish a basic, diluted or adjusted basis. Earnings-feed EPS may differ from statement EPS; the two series are not combined. Applies to Fact IDs:
earn.history.depth.2026-08-06.revenue_actual,earn.history.depth.2026-08-06.revenue_estimated,earn.history.depth.2026-08-06.revenue_actual.comparison,earn.history.depth.2026-08-06.eps_actual.comparison,earn.history.depth.2026-08-06.eps_actual,earn.history.depth.2026-08-06.eps_estimated,earn.history.depth.2026-05-07.revenue_actual,earn.history.depth.2026-05-07.revenue_estimated,earn.history.depth.2026-05-07.eps_actual,earn.history.depth.2026-05-07.eps_estimated,earn.history.depth.2026-02-26.revenue_actual,earn.history.depth.2026-02-26.revenue_estimated,earn.history.depth.2026-02-26.eps_actual,earn.history.depth.2026-02-26.eps_estimated,earn.history.depth.2025-11-06.revenue_actual,earn.history.depth.2025-11-06.revenue_estimated,earn.history.depth.2025-11-06.eps_actual,earn.history.depth.2025-11-06.eps_estimated. - Cash-flow note. Source series as of 2026-06-30. USD. Negative operating cash flow means cash used. Capital expenditure keeps the provider’s reported sign; it is not added here to estimate free cash flow or runway. Applies to Fact IDs:
fin.opcf.depth.2026-06-30.operating_cash_flow_m,fin.opcf.depth.2026-03-31.operating_cash_flow_m,fin.opcf.depth.2026-06-30.capex_m,fin.opcf.depth.2026-03-31.capex_m,fin.opcf.depth.2025-12-31.operating_cash_flow_m,fin.opcf.depth.2025-12-31.capex_m,fin.opcf.depth.2025-09-30.operating_cash_flow_m,fin.opcf.depth.2025-09-30.capex_m.
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Sources used for research written 2026-09-13
Historical evidence preserved with this analysis. Current figures are listed separately above.
| Evidence | Captured value | Source date | Source type | Source |
|---|---|---|---|---|
| Legal name | American Healthcare REIT, Inc. | 2026-02-27 | OFFICIAL | SEC EDGAR — 10-K filed 2026-02-27 |
| Sector / industry (provider taxonomy) | Real Estate / REIT - Healthcare Facilities The company's SEC filings classify it under SIC 6798 — Real Estate Investment Trusts. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) company profile |
| Business description | American Healthcare REIT (AHR) was forged through a significant strategic consolidation, combining Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, along with integrating the business and operations of American Healthcare Investors. This comprehensive merger has established AHR as a leading global real estate investment trust focused on healthcare properties, boasting an impressive portfolio with a gross investment value of approximately $4.2 billion. A core strength of the company lies in its fully integrated management platform, staffed by over one hundred highly experienced and proficient professionals. Many members of this team have a long history of collaboration, dating back to 2006, and have successfully invested in and overseen healthcare real estate assets across diverse market cycles. Their collective expertise, extensive industry network, and deep, firsthand understanding of each property within the international portfolio – which they have meticulously built and managed since its first acquisition in 2014 – are unparalleled. This powerful combination of a robust management team and a high-quality asset base strategically positions American Healthcare REIT to capitalize on compelling growth opportunities, driven by significant demographic trends. Its expansive portfolio encompasses 19 million square feet across 312 distinct properties, including medical office buildings, senior housing communities, skilled nursing facilities, and integrated senior health campuses. This diverse collection is strategically distributed across 36 U.S. states and the United Kingdom. The aforementioned tri-party transaction represented a pivotal step in ideally preparing American Healthcare REIT for a future public listing or Initial Public Offering (IPO) on a national stock exchange when market conditions are most favorable. By eventually listing its shares, the company anticipates gaining enhanced access to attractive capital sources, which will be crucial for fueling future expansion, diversifying its investor base, and providing greater liquidity for its existing stockholders. American Healthcare REIT, Inc. operates as a subsidiary of Griffin Capital Company, LLC. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) company profile |
| Revenue by segment | Resident Fees and Services: $2.09B | 2025-12-31 | FMP | Financial Modeling Prep (FMP) revenue segmentation, from the company's 10-K |
| Operating cash flow by quarter (USD millions) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q cash-flow statements |
| Cash, investments and debt | Total debt: $1.57B; Liquidity basis: cash and short-term investments; Total liabilities: $1.96B; Cash and short-term investments: $156.90M; Cash and investments: $249.40M; Long-term investments: $92.46M; Long-term investments classification: unclassified Long-term investments are shown separately; their marketability is not established by the provider field. The cash and short-term investment balance does not establish unrestricted availability. | 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's balance sheet |
| Employees | Count: 121 | 2025-12-31 | FMP | Financial Modeling Prep (FMP) employee count, from the company's filing |
| Quarterly income statement (USD thousands) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's 10-Q and 10-K income statements |
| Annual revenue and net result (USD millions) | Captured record · 5 entries
| 2025-12-31 | FMP | Financial Modeling Prep (FMP), from the company's 10-K income statements |
| Reported versus estimated, last 8 quarters | Captured record · 8 entries
| 2026-08-06 | FMP | Financial Modeling Prep (FMP) earnings |
| Most recent periodic reports | 2026-08-07 | OFFICIAL | SEC EDGAR filer submissions | |
| Cash and investment components | Total basis: cash short and long-term investments; Total: $249.40M; Cash and short-term investments: $156.90M; Long-term investments: $92.50M; Long-term investments classification: unclassified Sums the balance sheet's cash and short-term investments with its long-term investments.; The long-term investment field does not establish marketability; the sum is not a measure of available liquidity.; These provider fields do not establish investment access restrictions or explain differences from third-party cash figures. | 2026-06-30 | COMPUTED | Computed from the balance sheet |
| Cash and short-term investments over time (USD millions) | Captured record · 8 entries
| 2026-06-30 | FMP | Financial Modeling Prep (FMP), from the company's quarterly balance sheets |
| Trailing twelve-month ratio set | Quick ratio: 0.18; Current ratio: 0.18; Debt to equity: 0.42; Net margin: 4.8%; Gross margin: 14.9%; Operating margin: 6.7%; Return on assets: 2.1%; Return on equity: 3.7% Price-based multiples captured at research time are not repeated here; the page shows each once, from current figures with their own dates. A ratio our provider could not compute is absent rather than shown as zero. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) key-metrics-ttm + ratios-ttm |
| Distress and quality screens | Altman Z-score: 3.38; Piotroski F-score: 5 Altman Z below 1.8 is the conventional distress zone. The screen is built for manufacturers and industrials; for banks, insurers and property companies it is not a meaningful reading. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) financial scores |
| Recent dividends paid | Captured record · 4 entries
Declared amounts per share on their ex-dates. A single payment does not establish an annual rate, and a special dividend is not separated here. | 2026-06-30 | FMP | Financial Modeling Prep (FMP) dividend history |
| Dividends per share, last 12 months | $1.00 Sum of 4 payments with an ex-date in the 365 days to 2026-09-13. A past window, not a declared annual rate; a special dividend inside it is included. | 2026-06-30 | FMP | Financial Modeling Prep (FMP) dividend history |
| Dividend yield, last 12 months | 1.87% Payments made in the last 12 months divided by the close this page was built from. Backward-looking; it is not a forecast and the company has not declared it as a rate. | 2026-06-30 | FMP | Financial Modeling Prep (FMP) dividend history and quote |
| Next earnings report | Date: 2026-11-05; EPS estimate: $0.16 per share; Revenue estimate: $697.32M The date is our provider's estimate until the company confirms it. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) earnings calendar |
| Analyst revenue and earnings estimates (average) | Captured record · 4 entries
| 2026-09-13 | FMP | Financial Modeling Prep (FMP) analyst estimates |
| Recent SEC filings |
| 2026-09-02 | OFFICIAL | SEC EDGAR filer submissions |
| Named officers | CEO: Jeffrey T. Hanson; Officers: Alan Robert Peterson — Title: Vice President of Investor Relations & Finance; Jeff Hanson — Title: CEO & Chairman, Pay: $200,563, Born: 1971; Gabe Willhite — Title: President & COO, Pay: $1.34M; Danny Prosky — Title: President, CEO & Board of Director (Leave of Absence), Pay: $2.33M, Born: 1964; Mark Foster — Title: Executive Vice President, General Counsel & Secretary, Pay: $864,645, Born: 1973; Brian Peay — Title: Chief Financial Officer, Pay: $1.50M, Born: 1966; Kenny Lin — Title: Executive Vice President, Deputy Chief Financial Officer & Chief Accounting Officer, Born: 1977; Raymond Oborn — Title: Executive Vice President of Asset Management Titles and pay come from the company's proxy statement as our provider parsed it. | 2026-09-13 | FMP | Financial Modeling Prep (FMP) key executives (proxy-derived) |
Data provided for informational purposes only.
ETFs that hold AHR
Funds in our ETF coverage that list AHR among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
| ETF | Weight | Holdings as of |
|---|---|---|
| Federated Hermes MDT Small Cap Core ETF (FSCC) | 2.61% | |
| Deepwater Beachfront Small Cap ETF (DBSC) | 2.01% |